Morgan Stanley boosted its position in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 83.9% during the first quarter, Holdings Channel reports. The fund owned 122,149 shares of the medical equipment provider’s stock after buying an additional 55,720 shares during the period. Morgan Stanley’s holdings in Smith & Nephew SNATS were worth $3,777,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in SNN. Nuance Investments LLC increased its stake in shares of Smith & Nephew SNATS by 6.5% in the first quarter. Nuance Investments LLC now owns 2,147,255 shares of the medical equipment provider’s stock worth $66,415,000 after buying an additional 131,388 shares during the last quarter. Bbva Compass Bancshares Inc. increased its stake in shares of Smith & Nephew SNATS by 20.3% in the first quarter. Bbva Compass Bancshares Inc. now owns 40,733 shares of the medical equipment provider’s stock worth $1,260,000 after buying an additional 6,865 shares during the last quarter. Wrapmanager Inc. increased its stake in shares of Smith & Nephew SNATS by 12.2% in the first quarter. Wrapmanager Inc. now owns 9,971 shares of the medical equipment provider’s stock worth $308,000 after buying an additional 1,082 shares during the last quarter. Eqis Capital Management Inc. increased its stake in shares of Smith & Nephew SNATS by 35.6% in the first quarter. Eqis Capital Management Inc. now owns 39,587 shares of the medical equipment provider’s stock worth $1,224,000 after buying an additional 10,394 shares during the last quarter. Finally, Geneva Advisors LLC increased its stake in shares of Smith & Nephew SNATS by 4.2% in the first quarter. Geneva Advisors LLC now owns 34,027 shares of the medical equipment provider’s stock worth $1,052,000 after buying an additional 1,387 shares during the last quarter. Hedge funds and other institutional investors own 7.17% of the company’s stock.

Smith & Nephew SNATS, Inc. (SNN) traded up 0.833% on Wednesday, reaching $35.725. 46,140 shares of the company’s stock traded hands. The firm’s 50-day moving average is $34.92 and its 200 day moving average is $33.10. Smith & Nephew SNATS, Inc. has a 12 month low of $26.97 and a 12 month high of $35.85. The firm has a market cap of $15.64 billion, a PE ratio of 18.190 and a beta of 0.76.

WARNING: This piece of content was originally published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/morgan-stanley-has-3-78-million-stake-in-smith-nephew-snats-inc-snn/1495549.html.

A number of equities research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $40.00 price objective on the stock in a research note on Wednesday, June 7th. BidaskClub upgraded shares of Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a research note on Friday, June 23rd. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $38.00.

About Smith & Nephew SNATS

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew SNATS, Inc. (NYSE:SNN).

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.